Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Comparison of statins in hypertriglyceridemia

E A Stein1, M Lane, P Laskarzewski

  • 1Medical Research Laboratories, Highland Heights, Kentucky 41076, USA.

The American Journal of Cardiology
|April 4, 1998
PubMed
Summary

Statins effectively lower triglyceride levels, particularly in hypertriglyceridemic patients. Their efficacy in reducing triglycerides correlates with their LDL cholesterol-lowering ability, especially at higher baseline triglyceride levels.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Achievement of Target Gain Larger than Unity in an Inertial Fusion Experiment.

Physical review letters·2024
Same author

Cingulate circuits are associated with escalation of heroin use and naloxone-induced increases in heroin self-administration.

Addiction neuroscience·2023
Same author

Lawson Criterion for Ignition Exceeded in an Inertial Fusion Experiment.

Physical review letters·2022
Same author

Nicotine addiction: Translational insights from circuit neuroscience.

Pharmacology, biochemistry, and behavior·2021
Same author

IL-1α Modulates IFN-γ-Induced Production of CXCL9/MIG during Herpes Simplex Virus Type-1 Corneal Infection.

Current eye research·2020
Same author

Nicotine dependence (trait) and acute nicotinic stimulation (state) modulate attention but not inhibitory control: converging fMRI evidence from Go-Nogo and Flanker tasks.

Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology·2020

Area of Science:

  • Cardiovascular Medicine
  • Pharmacology
  • Metabolic Disorders

Background:

  • The introduction of 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitors (statins) in 1996 marked a significant advancement in managing lipid disorders.
  • Early studies indicated statin efficacy in reducing triglyceride levels, prompting further investigation into their broader application and effectiveness across different patient populations and dosages.

Purpose of the Study:

  • To determine if all statins are equally effective in lowering triglyceride levels.
  • To assess the relationship between statin effectiveness, drug type, dosage, and baseline triglyceride levels.
  • To establish a standardized method for comparing statin effects on triglycerides and low-density lipoprotein (LDL) cholesterol.

Main Methods:

  • A triglyceride/LDL cholesterol ratio was devised to standardize comparisons, calculated by dividing the percent change in triglycerides by the percent change in LDL cholesterol from baseline.

Related Experiment Videos

  • A pooled laboratory database of 2,689 subjects from 7 randomized, double-blind studies was analyzed.
  • Subjects with baseline triglyceride levels <400 mg/dL were included, with analyses stratified by baseline triglyceride levels (<150 mg/dL, 150-250 mg/dL, >250 mg/dL).

    • Main Results:

    • All statins demonstrated significant and dose-dependent reductions in triglyceride levels (22-45%) in subjects with baseline triglyceride levels >250 mg/dL.
    • No significant or dose-dependent effect on triglyceride levels was observed when baseline triglyceride levels were <150 mg/dL.
    • The triglyceride/LDL cholesterol ratio was significantly related only to the baseline triglyceride level (p <0.001) and was relatively constant across statins and doses within specific baseline triglyceride ranges.

    Conclusions:

    • All statins are effective in reducing triglyceride levels, but this effect is primarily observed in hypertriglyceridemic patients.
    • The effectiveness of statins in lowering triglycerides is directly proportional to their LDL cholesterol-lowering capacity, particularly in patients with elevated baseline triglycerides.
    • The triglyceride/LDL cholesterol ratio provides a reliable metric for assessing statin efficacy in triglyceride reduction, especially in hypertriglyceridemic individuals.